featured
Rituximab Plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rituximab Plus Lenalidomide in Advanced Untreated Follicular Lymphoma
N. Engl. J. Med 2018 Sep 06;379(10)934-947, F Morschhauser, NH Fowler, P Feugier, R Bouabdallah, H Tilly, ML Palomba, C Fruchart, EN Libby, RO Casasnovas, IW Flinn, C Haioun, H Maisonneuve, L Ysebaert, NL Bartlett, K Bouabdallah, P Brice, V Ribrag, N Daguindau, S Le Gouill, GM Pica, A Martin Garcia-Sancho, A López-Guillermo, JF Larouche, K Ando, M Gomes da Silva, M André, P Zachée, LH Sehn, K Tobinai, G Cartron, D Liu, J Wang, L Xerri, GA SallesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.